FDA Clearance Tracker · P200035-S007
OrganOx metra® System
Last checked: Nov 20, 2026Latest source record: Nov 20, 2023 (this decision)Source: openFDAMethods & limitations
Decided
Nov 20, 2023
Approved
Time to decision
276 days
Received Feb 17, 2023. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Normal 180 Day Track
Device class
Class III
The decision
- FDA number
- P200035-S007
- Device name
- OrganOx metra® System
- Applicant
- Organox Limited
- Applicant location
- Oxford
- Received
- Feb 17, 2023
- Decided
- Nov 20, 2023
- Decision
- Approved
- Supplement type
- Normal 180 Day Track
- Reason for supplement
- Change Design/Components/Specifications/Material
- Original approval
- P200035
Device type
- Device class
- Class III
FDA's approval statement
As written in FDA's record.
This 180-day PMA supplement requested approval for changes to the hardware and software of the OrganOx metra Retained Unit (Part Number D0003). These changes include the update of hardware components due to obsolescence and to facilitate electrical safety and electromagnetic compatibility (EMC) testing compliance. In addition, the software Operating System (OS) is updated from Windows 7 to Windows 10 and the Graphical User Interface (GUI) component of the system software is updated to accommodate the update to Windows 10 operating system.
Source documents
Other decisions for Organox Limited
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
P200035 · Decided Dec 9, 2021 · 512 days after receipt
Device type: Normothermic machine perfusion system for the preservation of donor livers prior to transplantation (QQK) · GI, Urology & Nephrology
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.